<DOC>
	<DOCNO>NCT02201511</DOCNO>
	<brief_summary>The study design understand blood concetration PF-06412562 metabolite , PF-06663872 , follow single oral dose modify release formulation . The study include two dos PF-06412562 modify release formulation understand proportionality . Effect food absorption PF-06412562 modify release formulation also investigate study .</brief_summary>
	<brief_title>A Healthy Volunteer Trial Gain Information About Blood Concentrations PF-06412562 After Oral Administration Modified Release Formulation Fasted Fed Conditions</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject nonchildbearing potential age 18 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) ; Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . A positive urine drug screen . Subjects attempt suicide past . Subjects unexplained history sudden death family</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>relative bioavailbility</keyword>
	<keyword>food effect</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>ALTERATION OF COGNITIVE FUNCTIONS</keyword>
</DOC>